Abby R Rosenberg1,2,3,4, Miranda C Bradford1, Krysta S Barton1,2, Nicole Etsekson1, Elizabeth McCauley5,6, J Randall Curtis7,8,9, Joanne Wolfe10,11,12, K Scott Baker3,4,13, Joyce P Yi-Frazier1. 1. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington. 2. Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, Washington. 3. Center for Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington. 4. Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington. 5. Center for Child Health, Behavior, and Development, Seattle Children's Research Institute, Seattle, Washington. 6. Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington. 7. Division of Pulmonary, Critical Care, and Sleep Medicine, Harborview Medical Center, Seattle, Washington. 8. Cambia Palliative Care Center of Excellence, University of Washington, Seattle, Washington. 9. Department of Medicine, University of Washington School of Medicine, Seattle, Washington. 10. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts. 11. Department of Medicine, Boston Children's Hospital, Boston, Massachusetts. 12. Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. 13. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract
BACKGROUND:Adolescents and young adults (AYAs) with cancer are at risk for poor psychosocial outcomes, perhaps because they have not acquired skills to navigate the adversities of illness. In a recent phase II randomized controlled trial (RCT), the "Promoting Resilience in Stress Management" (PRISM) intervention was associated with improved patient-reported resilience, quality of life, and distress. In this planned analysis of secondary aims, we hypothesized PRISM would also improve targeted coping skills of hopeful thinking, benefit finding, and goal setting. METHODS: We conducted this parallel RCT at Seattle Children's Hospital from January 2015 to October 2016. English-speaking AYAs (12-25 years old) with cancer were randomized one-to-one to PRISM or usual care (UC). PRISM teaches stress-management, goal-setting, cognitive-reframing, and meaning-making skills in four sessions delivered in-person every other week. Participants completed surveys at enrollment and 6 months later. Mixed effects linear regression models evaluated associations between PRISM and benefit finding (Benefit-Finding Scale for Children), hopeful thinking (Hope Scale), and an exploratory outcome of goal setting (queried with open-ended items about participant's goals, measured qualitatively by three blinded reviewers). RESULTS: Of N = 92 AYAs (48 PRISM, 44 UC), 73% were 12-17 years old, 43% female, and 62% diagnosed with leukemia or lymphoma. PRISM was associated with improved benefit finding and hope with moderate-to-large effect sizes-benefit finding: +3.1 points, 95% CI 0.0, 6.2, d = 0.4, and P = 0.05; and hope: +3.6 points, 95% CI 0.7, 6.4, d = 0.6, and P = 0.01. We did not detect changes in goal setting (-0.5 points, 95% CI -1.2, 0.3, d = -0.3, P = 0.23). CONCLUSIONS: PRISM was associated with improvements in benefit finding and hopeful thinking, two adaptive coping skills which may mitigate long-term psychosocial risk.
RCT Entities:
BACKGROUND: Adolescents and young adults (AYAs) with cancer are at risk for poor psychosocial outcomes, perhaps because they have not acquired skills to navigate the adversities of illness. In a recent phase II randomized controlled trial (RCT), the "Promoting Resilience in Stress Management" (PRISM) intervention was associated with improved patient-reported resilience, quality of life, and distress. In this planned analysis of secondary aims, we hypothesized PRISM would also improve targeted coping skills of hopeful thinking, benefit finding, and goal setting. METHODS: We conducted this parallel RCT at Seattle Children's Hospital from January 2015 to October 2016. English-speaking AYAs (12-25 years old) with cancer were randomized one-to-one to PRISM or usual care (UC). PRISM teaches stress-management, goal-setting, cognitive-reframing, and meaning-making skills in four sessions delivered in-person every other week. Participants completed surveys at enrollment and 6 months later. Mixed effects linear regression models evaluated associations between PRISM and benefit finding (Benefit-Finding Scale for Children), hopeful thinking (Hope Scale), and an exploratory outcome of goal setting (queried with open-ended items about participant's goals, measured qualitatively by three blinded reviewers). RESULTS: Of N = 92 AYAs (48 PRISM, 44 UC), 73% were 12-17 years old, 43% female, and 62% diagnosed with leukemia or lymphoma. PRISM was associated with improved benefit finding and hope with moderate-to-large effect sizes-benefit finding: +3.1 points, 95% CI 0.0, 6.2, d = 0.4, and P = 0.05; and hope: +3.6 points, 95% CI 0.7, 6.4, d = 0.6, and P = 0.01. We did not detect changes in goal setting (-0.5 points, 95% CI -1.2, 0.3, d = -0.3, P = 0.23). CONCLUSIONS:PRISM was associated with improvements in benefit finding and hopeful thinking, two adaptive coping skills which may mitigate long-term psychosocial risk.
Authors: C R Snyder; C Harris; J R Anderson; S A Holleran; L M Irving; S T Sigmon; L Yoshinobu; J Gibb; C Langelle; P Harney Journal: J Pers Soc Psychol Date: 1991-04
Authors: Sharyl J Nass; Lynda K Beaupin; Wendy Demark-Wahnefried; Karen Fasciano; Patricia A Ganz; Brandon Hayes-Lattin; Melissa M Hudson; Brenda Nevidjon; Kevin C Oeffinger; Ruth Rechis; Lisa C Richardson; Nita L Seibel; Ashley W Smith Journal: Oncologist Date: 2015-01-07
Authors: Abby R Rosenberg; Joyce P Yi-Frazier; Claire Wharton; Karen Gordon; Barbara Jones Journal: J Adolesc Young Adult Oncol Date: 2014-12-01 Impact factor: 2.223
Authors: Abby R Rosenberg; Miranda C Bradford; Kira Bona; Michele L Shaffer; Joanne Wolfe; K Scott Baker; Nancy Lau; Joyce Yi-Frazier Journal: J Psychosoc Oncol Date: 2017-11-03
Authors: Barbara L Andersen; Hae-Chung Yang; William B Farrar; Deanna M Golden-Kreutz; Charles F Emery; Lisa M Thornton; Donn C Young; William E Carson Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: Nancy Lau; Miranda C Bradford; Angela Steineck; Courtney C Junkins; Joyce P Yi-Frazier; Elizabeth McCauley; Abby R Rosenberg Journal: Psychooncology Date: 2019-05-14 Impact factor: 3.894
Authors: Kaitlyn M Fladeboe; Samantha Scott; Miranda C Bradford; Tyler G Ketterl; Joyce P Yi-Frazier; Abby R Rosenberg Journal: J Adolesc Young Adult Oncol Date: 2020-04-21 Impact factor: 2.223
Authors: Adrienne S Viola; Gary Kwok; Kristine Levonyan-Radloff; Sharon L Manne; Robert B Noll; Sean Phipps; Olle Jane Z Sahler; Katie A Devine Journal: Cancers (Basel) Date: 2022-06-25 Impact factor: 6.575
Authors: Joyce P Yi-Frazier; Maeve B O'Donnell; Elizabeth A Adhikari; Chuan Zhou; Miranda C Bradford; Samantha Garcia-Perez; Kelly J Shipman; Samantha E Hurtado; Courtney C Junkins; Alison O'Daffer; Abby R Rosenberg Journal: JAMA Netw Open Date: 2022-07-01
Authors: Angela Steineck; Krysta S Barton; Miranda C Bradford; Joyce P Yi-Frazier; Abby R Rosenberg Journal: J Adolesc Young Adult Oncol Date: 2021-05-06 Impact factor: 2.223
Authors: Nancy Lau; Miranda C Bradford; Angela Steineck; Samantha Scott; Kira Bona; Joyce P Yi-Frazier; Elizabeth McCauley; Abby R Rosenberg Journal: Palliat Med Date: 2019-11-04 Impact factor: 5.713
Authors: Samantha R Scott; Alison G O'Daffer; Miranda C Bradford; Kaitlyn Fladeboe; Nancy Lau; Angela Steineck; Mallory Taylor; Joyce P Yi-Frazier; Abby R Rosenberg Journal: Support Care Cancer Date: 2020-11-20 Impact factor: 3.359